Dana Pharmaceutical Company (DEDANA) balance sheet
Assets, liabilities and equity at the close of each period
- Ticker
- DEDANA
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/09/30 | To 1402/09/30 | To 1401/09/30 | To 1400/09/30 |
|---|---|---|---|---|---|---|
| Property, plant and equipment | 5,376,959 | 5,320,525 | 5,156,181 | 4,669,289 | 3,872,550 | 2,996,211 |
| Intangible assets | 200,835 | 203,536 | 203,373 | 12,054 | 8,623 | 8,217 |
| Long-term investments | 91 | 91 | 91 | 50,091 | 91 | 400,091 |
| Long-term receivables | 9,553 | 14,812 | 15,741 | 12,017 | 84,674 | 8,499 |
| Other assets | 71 | 1,216,071 | 1,216,071 | 71 | 12,071 | 71 |
| Total non-current assets | 5,587,509 | 6,755,035 | 6,591,457 | 4,743,522 | 3,978,009 | 3,413,089 |
| Orders and prepayments | 13,152,143 | 10,751,194 | 5,440,945 | 7,821,440 | 5,073,178 | 2,263,688 |
| Inventory of materials and goods | 26,365,308 | 13,009,433 | 10,107,673 | 8,417,973 | 5,339,610 | 4,338,082 |
| Trade and other receivables | 123,266,993 | 52,944,377 | 41,975,820 | 34,679,492 | 23,455,184 | 11,914,155 |
| Cash | 38,190,026 | 6,434,081 | 1,830,773 | 5,293,564 | 1,417,722 | 595,625 |
| Total current assets | 200,974,470 | 83,139,085 | 59,355,211 | 56,212,469 | 35,285,694 | 19,111,550 |
| Total assets | 206,561,979 | 89,894,120 | 65,946,668 | 60,955,991 | 39,263,703 | 22,524,639 |
| Capital | 14,400,000 | 7,200,000 | 7,200,000 | 2,400,000 | 2,400,000 | 2,400,000 |
| Legal reserve | 720,000 | 720,000 | 720,000 | 240,000 | 240,000 | 240,000 |
| Retained earnings (accumulated losses) | 63,494,905 | 25,323,834 | 17,803,105 | 17,654,610 | 12,434,806 | 8,253,720 |
| Treasury shares | -50,000 | -50,000 | -50,000 | 0 | 0 | 0 |
| Total equity | 78,564,905 | 33,193,834 | 25,673,105 | 20,294,610 | 15,074,806 | 10,893,720 |
| Employee end-of-service benefits provision | 1,500,519 | 814,606 | 547,866 | 236,088 | 156,713 | 141,848 |
| Total non-current liabilities | 1,500,519 | 814,606 | 547,866 | 236,088 | 198,226 | 295,508 |
| Trade and other payables | 50,470,304 | 9,693,342 | 7,624,845 | 5,227,724 | 3,925,917 | 1,148,254 |
| Tax payable | 17,513,346 | 4,867,322 | 4,415,683 | 5,135,766 | 4,045,312 | 2,384,049 |
| Dividends payable | 22,422,453 | 13,676,663 | 9,926,073 | 11,880,698 | 6,578,831 | 2,596,892 |
| Total current liabilities | 126,496,555 | 55,885,680 | 39,725,697 | 40,425,293 | 23,990,671 | 11,335,411 |
| Total liabilities | 127,997,074 | 56,700,286 | 40,273,563 | 40,661,381 | 24,188,897 | 11,630,919 |
| Total equity and liabilities | 206,561,979 | 89,894,120 | 65,946,668 | 60,955,991 | 39,263,703 | 22,524,639 |
Reporting periods
34 periods are on file for this report, from the period ending 1396/12/29 to the period ending 1405/06/31.